Evidence map›Paper›PMID 30576340›Full record

ArticlePloS one2018

Red blood cell phenotype fidelity following glycerol cryopreservation optimized for research purposes.

Stephen C Rogers, Laura B Dosier, Timothy J McMahon, Hongmei Zhu, David Timm, Hengtao Zhang, Joseph Herbert, Jacqueline Atallah, Gregory M Palmer, Asa Cook and 14 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 3 institutions in 1 country.

Stephen C RogersDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.ORCID 0000-0003-1139-4730
Laura B DosierDepartment of Pediatrics, Duke University School of Medicine, Durham, NC, United States of America.
Timothy J McMahonDepartment Medicine, Duke University School of Medicine, Durham, NC, United States of America.ORCID 0000-0002-3404-3223
Hongmei ZhuDepartment Medicine, Duke University School of Medicine, Durham, NC, United States of America.
David TimmDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.ORCID 0000-0003-1246-2707
Hengtao ZhangDepartment of Radiation Oncology, Duke Univ. School of Medicine, Durham, NC, United States of America.
Joseph HerbertDepartment of Radiation Oncology, Duke Univ. School of Medicine, Durham, NC, United States of America.
Jacqueline AtallahDepartment Medicine, Duke University School of Medicine, Durham, NC, United States of America.
Gregory M PalmerDepartment of Radiation Oncology, Duke Univ. School of Medicine, Durham, NC, United States of America.
Asa CookDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Melanie ErnstDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.ORCID 0000-0002-8995-3507
Jaya PrakashDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Mark TerngDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Parhom TowfighiDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.ORCID 0000-0003-2192-1143
Reid DoctorDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Ahmed SaidDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Matthew S JoensWashington University Center for Cellular Imaging, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
James A J FitzpatrickWashington University Center for Cellular Imaging, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Gabi HannaDepartment of Radiation Oncology, Duke Univ. School of Medicine, Durham, NC, United States of America.
Xue LinDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Julie A ReiszDepartment of Biochemistry, University of Colorado Denver-Aurora, CO, United States of America.
Travis NemkovDepartment of Biochemistry, University of Colorado Denver-Aurora, CO, United States of America.
Angelo D'AlessandroDepartment of Biochemistry, University of Colorado Denver-Aurora, CO, United States of America.
Allan DoctorDepartment of Pediatrics, Divisions of Critical Care Medicine, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, United States of America.
Washington University in St. Louis · USDuke University · USUniversity of Colorado Denver · US

Funding

Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
SEPSIS-INDUCED RED CELL DYSFUNCTION (SIRD)R01GM113838 · NIGMS · WASHINGTON UNIVERSITY · PI DOCTOR, ALLAN, MCMAHON, TIMOTHY J · 2015 to 2019
$4.0M
The Duke Multidisciplinary Training Program in Pediatric Lung DiseaseT32HL098099 · NHLBI · DUKE UNIVERSITY · PI MCMAHON, TIMOTHY J · 2010 to 2014
$660k
SNO transport regulates endothelial adhesion of RBCsI01BX003478 · VA · DURHAM VA MEDICAL CENTER · PI TIMOTHY J MCMAHON · 2017 to 2026
–
BLRD VA I01 BX003478NHLBI NIH HHS T32 HL007171NHLBI NIH HHS T32 HL098099NIGMS NIH HHS R01 GM113838
6 · The paper itself

Abstract

Intact red blood cells (RBCs) are required for phenotypic analyses. In order to allow separation (time and location) between subject encounter and sample analysis, we developed a research-specific RBC cryopreservation protocol and assessed its impact on data fidelity for key biochemical and physiological assays. RBCs drawn from healthy volunteers were aliquotted for immediate analysis or following glycerol-based cryopreservation, thawing, and deglycerolization. RBC phenotype was assessed by (1) scanning electron microscopy (SEM) imaging and standard morphometric RBC indices, (2) osmotic fragility, (3) deformability, (4) endothelial adhesion, (5) oxygen (O2) affinity, (6) ability to regulate hypoxic vasodilation, (7) nitric oxide (NO) content, (8) metabolomic phenotyping (at steady state, tracing with [1,2,3-13C3]glucose ± oxidative challenge with superoxide thermal source; SOTS-1), as well as in vivo quantification (following human to mouse RBC xenotransfusion) of (9) blood oxygenation content mapping and flow dynamics (velocity and adhesion). Our revised glycerolization protocol (40% v/v final) resulted in >98.5% RBC recovery following freezing (-80°C) and thawing (37°C), with no difference compared to the standard reported method (40% w/v final). Full deglycerolization (>99.9% glycerol removal) of 40% v/v final samples resulted in total cumulative lysis of ~8%, compared to ~12-15% with the standard method. The post cryopreservation/deglycerolization RBC phenotype was indistinguishable from that for fresh RBCs with regard to physical RBC parameters (morphology, volume, and density), osmotic fragility, deformability, endothelial adhesivity, O2 affinity, vasoregulation, metabolomics, and flow dynamics. These results indicate that RBC cryopreservation/deglycerolization in 40% v/v glycerol final does not significantly impact RBC phenotype (compared to fresh cells).

Indexed as

AnimalsBlood PreservationCell AdhesionCryopreservationCryoprotective AgentsErythrocyte DeformabilityErythrocyte IndicesErythrocytesErythrocyte TransfusionGlycerolHealthy VolunteersHemoglobinsHumansMetabolomeMiceMice, NudeCryoprotective AgentsGlycerolHemoglobins

Identifiers

PMID30576340
PMCPMC6303082
OpenAlexW2906160634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.